One of our greatest concerns over the past couple of months has been why the COVID rate in the UK has remained stubbornly high.
A major alert went out today regarding a high number of false positives from the highly touted Ellume test kits from Australia.
The advisory committee on immunization practices and the CDC director weighed in on the final US government recommendations for vaccination.
It looks like much of the world is emerging from a summer of COVID and is now on the downward side of the epidemic curve.
Earlier this week, a formal internal advisory report from the US FDA said that the data did support boosters for the general population.
As of the middle of this week, new case rates are down in more than half of the United States and the overall rate is down approximately 5%.
Over the last week, between 5 and 10% of US states have seen a downward trend in the number of cases, but, the overall upward trend in the US has not turned around.
The big news of the last week is that the first Covid vaccine has been fully approved for full licensure in the United States.
The FDA authorized what is not a booster, but guidance that primary immunization for immunocompromised individuals should consist of 3 shots.
The major discussion this week is whether Delta is crowding out other variants so rapidly it will run out of susceptible hosts over a 6-8 week period.